Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three‐Weekly Schedule in First‐Line Treatment of Ovarian Cancer

BACKGROUND: Conventional first‐line combination therapy for ovarian cancer comprises 6 cycles of adjuvant or neoadjuvant carboplatin (AUC5‐6) with paclitaxel (175 mg/m(2)) every 3 weeks (PC‐3W). Weekly scheduling of paclitaxel may maximize its antiangiogenic effect and reduce adverse effects. We com...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Safra, Tamar, Waissengrin, Barliz, Levy, Talya, Leidner, Ellie, Merose, Rotem, Matceyevsky, Diana, Grisaru, Dan, Laskov, Ido, Mishaan, Nadav, Shayzaf, Rotem, Wolf, Ido
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Gynecologic Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794189/
https://ncbi.nlm.nih.gov/pubmed/32657524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars